You just read:

Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients

News provided by

Spring Bank Pharmaceuticals, Inc.

Feb 28, 2013, 10:15 ET